Literature DB >> 9796719

Tenosynovial giant cell tumors: evidence for a desmin-positive dendritic cell subpopulation.

A L Folpe1, S W Weiss, C D Fletcher, A M Gown.   

Abstract

Diffuse tenosynovial giant cell tumor (DGCT) could present as a large intra-articular mass (pigmented villonodular synovitis, or PVNS) or as an extraarticular mass, which might be confused with a sarcoma, particularly when growth is destructive and giant cells are few. Prompted by a DGCT in which a subpopulation of cells was desmin positive and in which an erroneous diagnosis of myosarcoma was made, we analyzed the frequency of desmin, myogenin, MyoD1, and muscle-specific actin immunoreactivity in 45 well-characterized GCTs. We also analyzed a subset of these cases with antibodies to smooth muscle actin, as well as macrophage, follicular dendritic cell, extrafollicular dendritic cell, and dermal dendrocyte-associated antigens. Sections from 45 cases of formalin-fixed GCTs (22 DGCTs, 13 cases of PVNS, and 10 localized GCTs) were immunostained for desmin, myogenin, MyoD1, and muscle-specific actin. The eight cases that showed the largest number of desmin-positive cells were immunostained for smooth muscle actin, CD45, CD68, CD21, CD35, cytokeratin 8, and Factor XIIIa. Desmin-positive cells were seen in 20 (43%) of 45 cases: 10 (43%) of 22 DGCTs, 5 (38%) of 13 cases of PVNS, and 5 (50%) of 10 localized GCTs. In contrast, none were positive for any of the other muscle-associated proteins. In almost all of the cases, the desmin-positive cells were large and dendriform, with long processes that interdigitated between adjacent round cells. Desmin immunoreactivity was found in almost 50% of all GCTs, in the absence of positivity for other muscle markers. Desmin immunoreactivity in GCT seemed to be confined to a variably sized subpopulation of large dendritic cells whose exact identity remains uncertain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9796719

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  7 in total

1.  Myxoinflammatory fibroblastic sarcoma: a clinicopathologic analysis of 104 cases, with emphasis on predictors of outcome.

Authors:  William B Laskin; John F Fetsch; Markku Miettinen
Journal:  Am J Surg Pathol       Date:  2014-01       Impact factor: 6.394

Review 2.  Selected Giant Cell Rich Lesions of the Temporal Bone.

Authors:  Anthony P Martinez; Jorge Torres-Mora
Journal:  Head Neck Pathol       Date:  2018-08-01

Review 3.  Immunohistochemistry of soft tissue tumours - review with emphasis on 10 markers.

Authors:  Markku Miettinen
Journal:  Histopathology       Date:  2013-11-28       Impact factor: 5.087

4.  [Tenosynovial giant cell tumor].

Authors:  C Kuhnen; K-M Müller; S Rabstein; A Kasprzynski; P Herter
Journal:  Pathologe       Date:  2005-03       Impact factor: 1.011

5.  Tenosynovial giant cell tumour of the neck.

Authors:  P H Reece; K Y Lwin; P A Gurr
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-03-22       Impact factor: 2.503

6.  Malignant Tenosynovial Giant Cell Tumor: The True "Synovial Sarcoma?" A Clinicopathologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases, Supporting Origin from Synoviocytes.

Authors:  Alyaa Al-Ibraheemi; William Albert Ahrens; Karen Fritchie; Jie Dong; Andre M Oliveira; Bonnie Balzer; Andrew L Folpe
Journal:  Mod Pathol       Date:  2018-09-11       Impact factor: 7.842

Review 7.  Poorly-differentiated and undifferentiated sarcomas of the mediastinum: a bag of tricks.

Authors:  Salvatore Lorenzo Renne; Luca Di Tommaso
Journal:  Mediastinum       Date:  2021-03-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.